Members

The Viral Hepatitis Action Coalition is a public-private partnership developed by the CDC Foundation. Members of the Viral Hepatitis Action Coalition show a demonstrated commitment to helping CDC make meaningful advances in the prevention, screening and treatment of viral hepatitis. Coalition members help support crucial CDC-led research and programs and amplify CDC’s messages to the public to increase overall awareness of viral hepatitis.

Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
CDC Foundation
Genetech, A Member of the Roche Group
Gilead Sciences, Inc.
GlaxoSmithKline
Janssen Therapeutics
Merck Sharp & Dohme
National Viral Hepatitis Roundtable
OraSure Technologies
Vertex Pharmaceuticals